DCF — MAYO CLINIC HEALTH SYSTEM-FAIRMONT
Enterprise Value: $-57.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-57.6M
Enterprise Value
$-19.9M
PV of Cash Flows
$-37.8M
PV of Terminal Value
$-60.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $84.6M | $-2.7M | -3.0% | $-6.3M | $-5.7M |
| Year 2 | $87.2M | $-1.9M | -2.0% | $-5.6M | $-4.6M |
| Year 3 | $89.8M | $-1.1M | -1.0% | $-4.9M | $-3.7M |
| Year 4 | $92.5M | $-0.6M | -1.0% | $-4.6M | $-3.1M |
| Year 5 | $95.2M | $-0.4M | -0.0% | $-4.4M | $-2.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-57.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$82.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03689194702603028
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5